The future of medical imaging in the detection of early markers of disease.
Imaging techniques are a combination of a contrast mechanism, exogenous or endogenous, and an instrument to exploit that contrast. This final chapter of these two special issues of this journal points to possible ways to improve the ability of imaging systems to exploit markers of cancer in the early detection of that disease. The aim not only is to find cancer at an earlier, more treatable stage, but to determine whether the disease discovered is dangerous and to indicate the possibilities for successful treatment. These topics are explored for each imaging system, with an emphasis on directions for future improvements.
Croft
Barbara Y
BY
Cancer Imaging Program, National Cancer Institute, National Institutes of Health, Rockville, MD 20852, USA. croftb@mail.nih.gov
D015415:Biomarkers; D014408:Biomarkers, Tumor; D003952:Diagnostic Imaging / Q000379:methods*; D004848:Epithelium / Q000473:pathology; D005260:Female; D006801:Humans; D007089:Image Enhancement; D007091:Image Processing, Computer-Assisted / Q000379:methods*; D009369:Neoplasms / Q000209:etiology* / Q000473:pathology; D014057:Tomography, X-Ray Computed; D014965:X-Rays
D015415:Biomarkers; D014408:Biomarkers, Tumor